about
Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effectCD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cellsEpstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a proteinExpression of CD150 in tumors of the central nervous system: identification of a novel isoform.EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexesHodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.The multilevel regulation of CD95 signaling outcome.The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.FCRL6 receptor: expression and associated proteins.Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages.Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation.The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.Study on the Spatial Architecture of p53, MDM2, and p14ARF Containing ComplexesThe TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling
P50
Q24294513-0B300FED-5773-4491-91C5-EA9D7D0FB0CFQ24303493-D408900B-165E-435D-92BD-8872AC2C8350Q24317671-96DB193F-E051-4F16-9CA4-0A3C384E191DQ35566887-27805FA2-F246-485A-8B5F-F2762C0FA808Q36535405-E32772AA-B4B8-4B46-8D49-D532643D5897Q37832638-D42605B3-67F9-4451-B56F-B3CAFD5A66BFQ38052379-875E8BAC-6D6A-48C3-A699-48248634A314Q40438426-113FB94A-C60A-4D60-AAE0-C57C66E707EDQ41412768-40705FFA-E335-432E-98E2-EE27E010188BQ42372557-127FA224-75A4-46C5-BE8E-51F74DAE9143Q43644101-5A7F8653-3B48-49D8-AAB5-538C59AE8EC0Q45021703-A7D4F425-51FB-482B-92A2-3C2556C12842Q45375969-4A933F1D-E1E5-4F70-95B1-8E5B7750C323Q50026151-C1CCBEA8-FED3-42B6-A0F7-83512F35303FQ60709806-A7AC0454-70FF-4DE1-A4FD-53A7AD95E3DDQ63345302-24C49C98-14F5-4BAB-9E61-D835A8D17A72Q92862986-68D84865-F5E7-46C6-9CCE-1D0801912144
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria Yurchenko
@en
Mariia Yurchenko
@ast
Mariia Yurchenko
@es
Mariia Yurchenko
@nl
type
label
Maria Yurchenko
@en
Mariia Yurchenko
@ast
Mariia Yurchenko
@es
Mariia Yurchenko
@nl
altLabel
Mariia Yurchenko
@en
Mariya Yurchenko
@en
prefLabel
Maria Yurchenko
@en
Mariia Yurchenko
@ast
Mariia Yurchenko
@es
Mariia Yurchenko
@nl
P106
P21
P31
P496
0000-0002-0516-4747